A recent case study in the International Archives of Medicine reports success in a case study that combines cellular therapies for spinal cord injury treatment.
The patient, a 29-year-old male with an L1 crush fracture of the vertebral body, received stem cell therapy of umbilical cord matrix and allogeneic umbilical cord blood at 5 months, 8 months, and 14 months after his injury.
No adverse effects were noted and the treatments were well tolerated.
The patient recovered muscle, bowel, and sexual function and experienced a decrease in pain from recurring 10/10 level to occasional pain intensity of 3/10.
To read more, please see the original journal article, Feasibility of combination allogeneic stem cell therapy for spinal cord treatment: A case report.
To take advantage of medical breakthroughs, we believe that the injured must maintain excellent fitness and health. Won’t you help us share this message by volunteering your time today? Volunteer with Will2Walk.
